Clinical Trials for Zentalis Pharmaceuticals

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Zentalis Pharmaceuticals

Clinical Trials (7)

NCT06351332
ZAP-IT: ZN-c3 + Carboplatin + Pembrolizumab in MTNBC
PHASE1/PHASE2Recruiting
78 participants
Started: May 1, 2024 · Completed: Sep 1, 2029
5 conditions3 sponsors1 location
NCT06015659
ZN-c3 + Gemcitabine in Pancreatic Cancer
PHASE2Recruiting
34 participants
Started: Nov 16, 2023 · Completed: Jun 1, 2027
3 conditions4 sponsors1 location
NCT05128825
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
PHASE2Recruiting
170 participants
Started: Feb 17, 2022 · Completed: Jun 30, 2027
1 condition1 sponsor70 locations
NCT05198804
A Study of ZN-c3 and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer
PHASE1/PHASE2Active, not recruiting
117 participants
Started: Jan 27, 2022 · Completed: May 31, 2025
4 conditions1 sponsor20 locations
NCT04833582
A Study of ZN-c3 in Combination With Gemcitabine in Subjects With Osteosarcoma
PHASE1/PHASE2Active, not recruiting
84 participants
Started: Aug 1, 2021 · Completed: Dec 30, 2023
1 condition1 sponsor17 locations
NCT04814108
A Study of ZN-c3 in Women With Recurrent or Persistent Uterine Serous Carcinoma
PHASE2Recruiting
76 participants
Started: Jul 28, 2021 · Completed: May 31, 2025
1 condition1 sponsor52 locations
NCT04516447
A Study of ZN-c3 in Patients With Ovarian Cancer
PHASE1Recruiting
140 participants
Started: Oct 26, 2020 · Completed: Feb 28, 2027
4 conditions1 sponsor24 locations